Cyanidin-3-O-β-glucoside inhibits LPS-induced expression of inflammatory mediators through decreasing IκBα phosphorylation in THP-1 cells

Inflammation Research

Volumn 59, Issue 9, 2010, Pages 723-730

  Zhang, Yinghui ^a   Lian, Fuzhi ^b   Zhu, Yanna ^a   Xia, Min ^a   Wang, Qing ^a   Ling, Wenhua ^a   Wang, Xiang Dong ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cyanidin 3 O glucoside; I B ; IL 6; Inflammation; TNF

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; AUTACOID; BETA ACTIN; CYANIDIN 3 O BETA GLUCOSIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTHOCYANINS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GLUCOSIDES; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; NF-KAPPA B; NITRILES; PHOSPHORYLATION; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955658816     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0183-7     Document Type: Article

References (42)

1. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 860 867 10.1038/nature05485 1:CAS:528:DC%2BD28XhtlShtrzK 17167474
2. SP Weisberg D McCann M Desai M Rosenbaum RL Leibel AW Ferrante Jr 2003 Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 1796 1808 1:CAS:528:DC%2BD3sXhtVSmtLvO 14679176
3. F Spah 2008 Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach Br J Dermatol 159 Suppl 2 10 17 10.1111/j.1365-2133.2008.08780.x 18700910
4. H Xu GT Barnes Q Yang G Tan D Yang CJ Chou, et al. 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 1821 1830 1:CAS:528:DC%2BD3sXhtVSmtLvI 14679177
5. PS Hsieh 2008 Inflammatory change of fatty liver induced by intraportal low-dose lipopolysaccharide infusion deteriorates pancreatic insulin secretion in fructose-induced insulin-resistant rats Liver Int 28 1167 1175 1:CAS:528:DC%2BD1cXhtFWmsL3O 18397237
6. MA Miller PG McTernan AL Harte NF Silva P Strazzullo KG Alberti, et al. 2009 Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population Atherosclerosis 203 494 502 10.1016/j.atherosclerosis.2008.06.018 1:CAS:528:DC%2BD1MXjslyitb8%3D 18672240
7. A Yamashita Y Soga Y Iwamoto S Yoshizawa H Iwata S Kokeguchi, et al. 2007 Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide Obesity 15 2549 2552 10.1038/oby.2007.305 1:CAS:528:DC%2BD1cXkvVGqsQ%3D%3D 18070744
8. G Odrowaz-Sypniewska 2007 Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome Adv Med Sci 52 246 250 1:CAS:528:DC%2BD1cXks12kug%3D%3D 18217426
9. A Guilherme JV Virbasius V Puri MP Czech 2008 Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes Nat Rev Mol Cell Biol 9 367 377 10.1038/nrm2391 1:CAS:528:DC%2BD1cXkvF2gt7k%3D 18401346
10. K Eder N Baffy A Falus AK Fulop 2009 The major inflammatory mediator interleukin-6 and obesity Inflamm Res 58 727 736 10.1007/s00011-009-0060-4 1:CAS:528:DC%2BD1MXht1eksLnI 19543691
11. P Hu Z Han AD Couvillon RJ Kaufman JH Exton 2006 Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression Mol Cell Biol 26 3071 3084 10.1128/MCB.26.8.3071-3084.2006 1:CAS:528:DC%2BD28Xjs1Sltrc%3D 16581782
12. T Seimon I Tabas 2009 Mechanisms and consequences of macrophage apoptosis in atherosclerosis J Lipid Res 50 Suppl S382 S387 10.1194/jlr.R800032-JLR200 18953058
13. H Zhang Y Park J Wu X Chen S Lee J Yang, et al. 2009 Role of TNF-alpha in vascular dysfunction Clin Sci (Lond) 116 219 230 10.1042/CS20080196 1:CAS:528:DC%2BD1MXis1OjtA%3D%3D
14. C Popa MG Netea T Radstake JW Van der Meer AF Stalenhoef PL van Riel, et al. 2005 Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis Ann Rheum Dis 64 303 305 10.1136/ard.2004.023119 1:CAS:528:DC%2BD2MXhvFyrurs%3D 15231512
15. SW Hu C Bevona L Winterfield AA Qureshi VW Li 2009 Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case Arch Dermatol 145 437 439 10.1001/archdermatol.2009.6 1:CAS:528:DC%2BD1MXlt1Gjsb8%3D 19380665
16. FC Huvers C Popa MG Netea FH van den Hoogen CJ Tack 2007 Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases Ann Rheum Dis 66 558 559 10.1136/ard.2006.062323 1:CAS:528: DC%2BD2sXkvFeksLw%3D 17360784
17. KS Ahn BB Aggarwal 2005 Transcription factor NF-kappaB: a sensor for smoke and stress signals Ann N Y Acad Sci 1056 218 233 10.1196/annals.1352.026 1:CAS:528:DC%2BD28XptFyisA%3D%3D 16387690
18. A Kumar Y Takada AM Boriek BB Aggarwal 2004 Nuclear factor-kappaB: its role in health and disease J Mol Med 82 434 448 10.1007/s00109-004-0555-y 1:CAS:528:DC%2BD2cXlsVCqsb4%3D 15175863
19. F Galvano L La Fauci P Vitaglione V Fogliano L Vanella C Felgines 2007 Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides Ann Ist Super Sanita 43 382 393 1:CAS:528:DC%2BD1cXjt12nu7o%3D 18209272
20. R Sasaki N Nishimura H Hoshino Y Isa M Kadowaki T Ichi, et al. 2007 Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice Biochem Pharmacol 74 1619 1627 10.1016/j.bcp.2007.08.008 1:CAS:528:DC%2BD2sXht1aktrjN 17869225
21. M Ding R Feng SY Wang L Bowman Y Lu Y Qian, et al. 2006 Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity J Biol Chem 281 17359 17368 10.1074/jbc.M600861200 1:CAS:528:DC%2BD28XlvVGkt7k%3D 16618699
22. TH Kang JY Hur HB Kim JH Ryu SY Kim 2006 Neuroprotective effects of the cyanidin-3-O-beta-d-glucopyranoside isolated from mulberry fruit against cerebral ischemia Neurosci Lett 391 122 126 10.1016/j.neulet.2005.08.053 1:CAS:528:DC%2BD2MXht1OksrjM 16181734
23. A Tarozzi F Morroni S Hrelia C Angeloni A Marchesi G Cantelli-Forti, et al. 2007 Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells Neurosci Lett 424 36 40 10.1016/j.neulet.2007.07.017 1:CAS:528:DC%2BD2sXpsFantLk%3D 17709193
24. T Tsuda F Horio K Uchida H Aoki T Osawa 2003 Dietary cyanidin 3-O-beta-d-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice J Nutr 133 2125 2130 1:CAS:528:DC%2BD3sXmsFOmurw%3D 12840166
25. SJ Duthie 2007 Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process Mol Nutr Food Res 51 665 674 10.1002/mnfr.200600257 1:CAS:528:DC%2BD2sXmvFamsrw%3D 17487926
26. N Matsunaga S Imai Y Inokuchi M Shimazawa S Yokota Y Araki, et al. 2009 Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo Mol Nutr Food Res 53 869 877 10.1002/mnfr.200800394 1:CAS:528:DC%2BD1MXpsV2lurg%3D 19415665
27. HM Herath Y Takano-Ishikawa K Yamaki 2003 Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharide- stimulated mouse macrophage cell line J774.1 J Med Food 6 365 370 10.1089/109662003772519930 14977446
28. XH Jin K Ohgami K Shiratori Y Suzuki Y Koyama K Yoshida, et al. 2006 Effects of blue honeysuckle (Lonicera caerulea L.) extract on lipopolysaccharide-induced inflammation in vitro and in vivo Exp Eye Res 82 860 867 10.1016/j.exer.2005.10.024 1:CAS:528:DC%2BD28XhtFejsrk%3D 16309673
29. Q Wang M Xia C Liu H Guo Q Ye Y Hu, et al. 2008 Cyanidin-3-O-beta- glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages Life Sci 83 176 184 10.1016/j.lfs.2008.05.017 1:CAS:528:DC%2BD1cXovF2itbY%3D 18619979
30. JW Pierce R Schoenleber G Jesmok J Best SA Moore T Collins, et al. 1997 Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J Biol Chem 272 21096 21103 10.1074/jbc.272.34.21096 1:CAS:528: DyaK2sXls1Ojtrs%3D 9261113
31. EW Jeffes 3rd JL McCullough MR Pittelkow A McCormick J Almanzor G Liu, et al. 1995 Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate J Invest Dermatol 104 183 188 10.1111/1523-1747.ep12612745 7829873
32. SN Fedorov TN Makarieva AG Guzii LK Shubina JY Kwak VA Stonik 2009 Marine two-headed sphingolipid-like compound rhizochalin inhibits EGF-induced transformation of JB6 P(+) Cl41 cells Lipids 44 777 785 10.1007/s11745-009-3322- 6 1:CAS:528:DC%2BD1MXhtFaqt77J 19579043
33. RL Prior X Wu 2006 Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities Free Radic Res 40 1014 1028 10.1080/10715760600758522 1:CAS:528:DC%2BD28XhtVymurvE 17015246
34. MA Collart P Baeuerle P Vassalli 1990 Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B Mol Cell Biol 10 1498 1506 1:CAS:528:DyaK3cXhslKktb0%3D 2181276
35. R Deshpande H Khalili RG Pergolizzi SD Michael MD Chang 1997 Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages Am J Reprod Immunol 38 46 54 1:STN:280:DyaK2svhtV2lsw%3D%3D 9266010
36. R Galien HF Evans T Garcia 1996 Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens Mol Endocrinol 10 713 722 10.1210/me.10.6.713 1:CAS:528:DyaK28XjsVSqsLk%3D 8776731
37. U Dendorfer P Oettgen TA Libermann 1994 Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide Mol Cell Biol 14 4443 4454 1:CAS:528:DyaK2cXltlWqt78%3D 8007951
38. JA DiDonato M Hayakawa DM Rothwarf E Zandi M Karin 1997 A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB Nature 388 548 554 10.1038/41493 1:CAS:528:DyaK2sXlt1arur4%3D 9252186
39. F Mercurio H Zhu BW Murray A Shevchenko BL Bennett J Li, et al. 1997 IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 278 860 866 10.1126/science.278.5339.860 1:CAS:528: DyaK2sXmvFOqu7o%3D 9346484
40. E Zandi DM Rothwarf M Delhase M Hayakawa M Karin 1997 The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 91 243 252 10.1016/S0092-8674(00)80406-7 1:CAS:528:DyaK2sXntVyiu7Y%3D 9346241
41. O Le Bail R Schmidt-Ullrich A Israel 1993 Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family EMBO J 12 5043 5049 1:CAS:528: DyaK2cXht1KktL0%3D 8262046
42. CY Ito N Adey VL Bautch AS Baldwin Jr 1995 Structure and evolution of the human IKBA gene Genomics 29 490 495 10.1006/geno.1995.9977 1:CAS:528: DyaK2MXovVSlsbk%3D 8666399